five

Supplementary Material for: Protective Effects of ACEI/ARB on Left Ventricular Function in Anthracycline-Induced Chronic Cardiotoxicity: A Meta-Analysis of Randomized Controlled Trials

收藏
DataCite Commons2021-05-04 更新2024-07-28 收录
下载链接:
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Protective_Effects_of_ACEI_ARB_on_Left_Ventricular_Function_in_Anthracycline-Induced_Chronic_Cardiotoxicity_A_Meta-Analysis_of_Randomized_Controlled_Trials/14534682
下载链接
链接失效反馈
官方服务:
资源简介:
<b><i>Purpose:</i></b> Cardiotoxicity is an important side effect of anthracycline. Cardioprotective drugs for anthracycline remain inconclusive. We attempted to determine the role of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) in the prevention of anthracycline-induced cardiotoxicity. <b><i>Hypothesis:</i></b> Prophylactic use of ACEI/ARB reduces the clinical or subclinical cardiotoxicity of anthracycline. <b><i>Methods:</i></b> Randomized controlled trials (RCTs) of ACEI/ARB in the prevention of anthracycline-induced cardiotoxicity were obtained by searching Pubmed, Embase, Web of Science, and Cochrane databases. 7 studies were finally included. A meta-analysis was performed on the 7 studies. The end points were changes in left ventricle ejection fraction (LVEF), early and late diastolic peak velocity ratio (<i>E</i>/<i>A</i>), and occurrence of hypotensive events. <b><i>Results:</i></b> Prophylactic use of ACEI/ARB has potential benefits for anthracycline-induced cardiotoxicity. LVEF was better preserved in the experimental group than in the control group (weighted mean difference [WMD] −3.16%, 95% confidence interval [CI] [−5.78, −0.54], <i>p</i> = 0.02). Follow-up time, tumor type, drug type, and geographical region did not affect the results. There was no significant benefit of <i>E</i>/<i>A</i> in the experimental group (WMD 0.02, 95% CI [−0.06, 0.11], <i>p</i> = 0.58), and no increase in the incidence of hypotension (risk ratio 3.79, 95% CI [0.44, 32.89], <i>p</i> = 0.23). <b><i>Conclusions:</i></b> We found that prophylactic use of ACEI/ARB reduced the clinical or subclinical cardiotoxicity of anthracycline, and the increase in hypotensive events was not significant. Due to the relatively small number of clinical studies and participants, more related studies are necessary to further verify our results.
提供机构:
Karger Publishers
创建时间:
2021-05-04
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作